Status:
COMPLETED
Visual Health Evaluation of New Designed Blue-blocking Glasses
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Blue-blocking Glasses
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
With the widespread use of electronic display devices, the potential hazards of blue light have become an important public health issue. The primary assessment and main outcome indicators of this expe...
Eligibility Criteria
Inclusion
- 1\. Adult population, regardless of gender 2. Refractive error is less than or equal to -2.5D and both eyes achieve corrected visual acuity of 0.8 or higher. 3. Normal intraocular pressure with no organic pathology. 4. No apparent symptoms of dry eye. 5. Willing to cooperate to complete all the tests. 6. Voluntarily signing the informed consent form.
Exclusion
- 1: Individuals with strabismus and amblyopia exist. 2: Suffering from congenital eye conditions such as congenital cataracts or congenital retinal diseases.
- 3: Those who have undergone intraocular surgery (such as cataract removal, intraocular lens implantation, etc.).
- 4: Individuals with refractive media opacity (such as corneal lesions, lens opacity, etc.).
- 5: Abnormal intraocular pressure (IOP) (IOP \< 10 mmHg or IOP \> 21 mmHg, or a bilateral IOP difference of ≥5 mmHg).
- 6: Abnormal intraocular pressure (IOP) (IOP \< 10 mmHg or IOP \> 21 mmHg, or a bilateral IOP difference of ≥5 mmHg).
- 7: Only one eye meets the inclusion criteria. 8: Active corneal infections such as bacterial, fungal, viral, or other acute or chronic anterior segment inflammations.
- 9: Currently using medications that may lead to dry eye or affect vision and corneal curvature.
- 10: Other ocular conditions, such as dacryocystitis, eyelid disorders and abnormalities, abnormal intraocular pressure, and glaucoma.
- 11: Unable to undergo regular eye examinations.
Key Trial Info
Start Date :
April 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06984783
Start Date
April 18 2025
End Date
July 10 2025
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospitol,Capital Medical University
Beijing, Beijing/China, China, 100730